Novel aspects of vitamin C in epoetin response

Journal of the Chinese Medical Association

Volumn 70, Issue 9, 2007, Pages 357-360

  Tarng, Der Cherng ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Erythropoietin; Hemodialysis; Vitamin C

Indexed keywords

ASCORBIC ACID; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADJUVANT THERAPY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROPOIESIS; EVIDENCE BASED MEDICINE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; LOW DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 35348860816     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70020-0     Document Type: Review

References (28)

1. Hörl WH. Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol Dial Transplant 1999;14(Suppl): 50-60.
2. Tarng DC, Huang TP, Wei YH. Erythropoietin and iron: the role of ascorbic acid. Nephrol Dial Transplant 2001;16(Suppl):35-9.
3. Macdougall IC. Metabolic adjuvants to erythropoietin therapy. Miner Electrolyte Metab 1999;25:357-64.
4. Gastaldello K, Vereerstraeten A, Nzame-Nze T, Vanherweghem JL, Tielemans C. Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant 1995;10(Suppl):44-7.
5. Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency (a clinical trial). J Nephrol 2000;13:444-9.
6. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M. Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 2002;26:366-70.
7. Keven K, Kutlay S, Nergizoglu G, Erturk S. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 2003;41:1233-9.
8. Tarng DC, Huang TP. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. Nephrol Dial Transplant 1998;13:2867-72.
9. Tarng DC, Huang TP, Chen TW. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int 1999;55(Suppl):S107-18.
10. Tarng DC, Wei YH, Huang TP, Kuo BIT. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 1999;55:2477-86.
11. Attallah N, Osman-Malik Y, Frinak S, Besarab A. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis 2006;47:644-54.
12. Deira J, Diego J, Martinez R, Oyarbide A, Gonzalez A, Diaz H, Grande J. Comparative study of intravenous ascorbic acid versus low-dose desferrioxamine in patients on hemodialysis with hyperferritinemia. J Nephrol 2003;16:703-9.
13. Lin CL, Hsu PY, Yang HY, Huang CC. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Ren Fail 2003;25:445-53.
14. Taji Y, Morimoto T, Okada K, Fukuhara S, Fukui T, Kuwahara T. Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients. J Nephrol 2004;17: 537-43.
15. Nguyen TV. Oral ascorbic acid as adjuvant to epoetin alfa in hemodialysis patients with hyperferritinemia. Am J Health-Syst Ph 2004;61:2007-8.
16. Chan D, Irish A, Dogra G. Efficacy and safety of oral versus intravenous ascorbic acid for anemia in hemodialysis patients. Nephrology (Carlton) 2005;10:336-40.
17. Tovbin D, Markowitz A, Mostoslavsky M, Landver R. Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight. Clin Nephrol 2000;53:276-82.
18. Mydlik M, Derzsiova K, Boldizsar J, Hribikova M, Petrovicova J. Oral use of iron with vitamin C in hemodialyzed patients. J Ren Nutr 2003;13:47-51.
19. Tarng DC, Hung SC, Huang TP. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients. J Am Soc Nephrol 2004;15:2486-93.
20. Bienfait HF, Van Del Briel ML. Rapid mobilization of ferritin iron by ascorbate in the presence of oxygen. Biochim Biophys Acta 1980;631:507-10.
21. Goldberg A. The enzymic formation of haem by the incorporation of iron into protoporphyrin; importance of ascorbic acid, ergothioneine and glutathione. Br J Haemat 1959;5:150-7.
22. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int 2006;69:706-14.
23. Ziouzenkova O, Asatryan L, Tetta C, Wratten ML, Hwang J, Sevanian A. Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants. Free Radic Biol Med 2002;33:248-58.
24. Tarng DC, Liu TY, Huang TP. Protective effect of vitamin C medication on 8-hydroxy 2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int 2004;66:820-31.
25. Canavese C, Petraulo M, Massarenti P, Berutti S, Fenoglio R, Rauletto D, Lanfranco G, et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005;45:540-9.
26. Deicher R, Ziai F, Habicht A, Bieglmayer C, Schillinger M, Hörl WH. Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant 2004; 19:2319-24.
27. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH. Low total vitamin C plasma level is a risk for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16:1811-8.
28. Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int 2003;63:1433-42.